While clinical trials have proven that it works, the approval limits its official use to this particular medical issue
Neurology 57:15151517 Coles LD, Tuite PJ, Oz G, Mishra UR, Kartha RV, Sullivan KM, Cloyd JC, Terpstra M (2018) Repeated-dose oral N-acetylcysteine in Parkinson's disease: pharmacokinetics and effect on brain glutathione and oxidative stress
However, BSO and GSSG administration substantially inhibited the expression of all these genes compared with the only CHT treatment
Australian TGA consumer warning Key Takeaway Complete overview of Melanotan II side effects including nausea, facial flushing, mole changes, and cardiovascular considerations with frequency data and management tips
If you use gray-market stuff, you put both your patients and your practice at risk
That said, some patients report subjective increases in urination after starting therapy